Publications by authors named "Timo Piironen"

Claim this Profile
F
Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles.
Joanne Goodman, Simon Cowen, Viswanath Devanarayan, David Egging, Thomas Emrich, Timo Piironen

Bioanalysis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the challenges of biomarker calibration standards in ligand-binding assays: a European Bioanalysis Forum perspective.
Ulrich Kunz, Joanne Goodman, Ulf Loevgren, Timo Piironen, Karen Elsby

Bioanalysis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma.
Lynn E Spitler, Huynh Cao, Timo Piironen, Theresa L Whiteside, Robert W Weber

Am J Clin Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
Timo Piironen, Alexander Haese, Hartwig Huland, Thomas Steuber, Ib Jarle Christensen

Clin Chem· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.
David Ulmert, Charlotte Becker, Jan-Ake Nilsson, Timo Piironen, Thomas Björk

Clin Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients.
Sisse Rye Ostrowski, Timo Piironen, Gunilla Høyer-Hansen, Jan Gerstoft, Bente Klarlund Pedersen

J Acquir Immune Defic Syndr· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific immunoassays for detection of intact and cleaved forms of the urokinase receptor.
Timo Piironen, Birgitte Laursen, Jesper Pass, Karin List, Henrik Gårdsvoll

Clin Chem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients.
Sisse R Ostrowski, Terese L Katzenstein, Timo Piironen, Jan Gerstoft, Bente K Pedersen

J Acquir Immune Defic Syndr· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
Charlotte Becker, Timo Piironen, Kim Pettersson, Jonas Hugosson, Hans Lilja

J Urol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.
Mads N Holten-Andersen, Ib Jarle Christensen, Hans Jørgen Nielsen, Hans Lilja, Gillian Murphy, Timo Piironen

Clin Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.
Rikke Riisbro, Ib J Christensen, Timo Piironen, Michael Greenall, Berthe Larsen

Clin Cancer Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis